Group items tagged

North America dominated the market in 2013 and will continue to drive and dominate it by 2018. However, the market share of this region will decrease to 34.5%, primarily due to the sequestration cuts announced in the U.S., which have resulted in lower investments from the government in research activities supporting proteomics. At the same time, Asia and Latin America are poised to grow at a CAGR of 17% to 22% in the forecast period; this growth is largely driven by the growing research base in these regions and the increasing pharmaceutical research related to drug discovery and drug development, and diagnostics product development activities in these regions.

On the basis of regions, the market is divided into North America, Europe, Asia, and the Rest of the World (RoW). The Rest of the World region comprises Latin America, Pacific countries, and Middle East and Africa. In 2014, North America accounted for the largest share of the antibody production market, followed by Europe and Asia. However, the Asian market is slated to grow at the highest CAGR in the coming five years and serves as a revenue pocket for the companies offering antibody productions.

Market Overview: Next-generation antibody therapeutics includes the use of new improvised therapeutic antibody to form innovative medicines for treating various diseases. Next-generation antibody therapeutics is developed clinically by pharmaceutical and biotechnology companies for several diseases. The Next Generation Antibody Therapeutics Market size was worth $ XX million in 2018 and is forecasted to reach $ XX million by 2026, expected to grow at a high CAGR during the forecast period 2019-2026. Market Dynamics: The Next Generation Antibody Therapeutics Market is growing due to several factors such as rising incidence of chronic diseases, increasing emergence of antibody technology, new drug discovery, large number of government initiatives, and growing research and development activities for new therapies. Rising prevalence of chronic disease such as cancer, asthma, diabetes and COPD are boosting the growth of the next generation antibody therapeutics market. For instance, according to National Cancer Institute in 2018, in United States, an estimated 1,735,350 new cases of cancer will be diagnosed and 609,640 people will die from the disease. The development of next-generation monoclonal antibodies has expanded beyond oncology into all therapeutic areas. For instance, ADCs were initially focused primarily on cancer, but Genentech has applied to infectious diseases, leading to the discovery and development of THIOMAB antibiotic conjugates (TACs) for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). The technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, hence, driving the growth in the next-generation antibody therapeutics market. However, stringent government regulation, high cost and time required for research and development activities are some of the factors hindering the growth for global next-generation antibody therapeutics market. Market Segmentation: Based o

[No of Slides - 147] Browse 10 tables and 36 figures/charts on Optical Imaging Market report covers the global market based on Technological aspects of Optical Coherence Tomography (OCT), Hyper Spectral Imaging (HSI), Photo Acoustic Tomography (PAT), Key Drivers & Geographic Regions covered.

Dental Implants & Prosthetics Market (Artificial Teeth, Dentures, Crowns & Bridges) Current Trends, Opportunities & Global Forecasts to 2016

A humble start by M. K. Narasinga Rao and Chitra krishnan into health care sector, Magal health care was formed in 2009, dealing products with international quality compliance ensuring not only complete credibility of the products but also credible services to the customers and in turn their customers. Based on extensive long term experience of distribution and experience in sales and marketing of medical devices & medical consumables within the sub-continent region, and with a comprehensive understanding of the challenges facing International Principles, We provide them with single channel of communication & single point of management . We take all the necessary steps in order to provide our patients with Access to the state of the art Medical technologies and Medical devices of the highest standard whilst still delivering Value for Money. With an ability to be sensitive towards market dynamism, Magal is evolving continuously, offering a better and wider spectrum of products that are innovative, affordable and at the forefront of medical technology to its valued clients. We carry out our business with the highest level of ethics and morality, adopting a strict code of conduct in keeping with those of the medical profession. The Future Magal Healthcare envisages adding more no of healthcare products to its current list that will enable it to provide more comprehensive solutions to meet the ever growing product and process demands of customers. Customer base The great amount of trust and faith reposed by customers in Magal Healthcare's capabilities is evident from its long list of customers, who always turn to Magal Healthcare to fulfill their ever growing requirements. Magal Healthcare Pvt. Ltd. to be identified by the industry as one stop shop for all healthcare related equipment distributor and equipped with sufficient, proper people for sales, service and administration. Visit:http://magal.in

The global sleep apnea devices market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America will continue to lead the sleep apnea device market in the years to come, followed by Europe. As reimbursement policies become more consistent across European countries, sustained steady growth is expected from the region in the coming years. The Asian region's contribution to the global sleep apnea device market is expected to pick up in the coming years as the medical condition gets more recognition from both patients and the medical fraternity alike.

North America dominated the market, with the U.S. accounting for a major market share. Asia is poised to grow at the highest CAGR during the forecast period. The large share of the North American market can be attributed to factors such as rising incidences of chronic diseases, expanding biotechnology and pharmaceutical industries, government support, and the launch of new products in the region.

AtlantiCare Regional Medical Center raises money to donate AEDs to Ventnor Middle School.

The goal is to help clinicians effectively manage negative emotional responses that might otherwise threaten future professional competence, patient care, and safety. Anecdotal feedback suggests that those professionals involved in such events have meaningfully benefited from the program.